Concord Medical Services Holdings, headquartered in Beijing, operates radiotherapy and diagnostic imaging centers across China, employing 727 staff and managing around 130 cooperative centers in 60 cities. The company went public on December 11, 2009.
CCM has been in the news recently: The global monoclonal antibodies market is projected to grow significantly, reaching USD 804.7 billion by 2033, with a compound annual growth rate (CAGR) of 12.5%. Additionally, the global pet insurance market is anticipated to expand from USD 11.8 billion in 2024 to USD 54.6 billion by 2033.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.